NCT02413918 - Iloperidone in Mixed States of Bipolar Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Bipolar Disorder

Interventions

DRUG

iloperidone

Qualifying subjects will take iloperidone starting at 2mg and up to a minimum of 12mg, maximum of 24mg, for 20 weeks in conjunction to the subjects current lithium, and or divalproex, and or lamotrigine.

Trial Locations (1)

78229

UT Health Science Center San Antonio, San Antonio